Objective  To understand parents' preferences and willingness to pay for human papilloma virus (HPV) vaccine for female students of secondary school, so as to provide a decision-making basis for policymakers and vaccine authorities.

Methods  A combination of simple random sampling and convenience sampling was used to conduct a discrete selection experimental questionnaire survey of 200 parients of secondary female students in Urumqi city in June 2022. The questionnaire was developed using a discrete choice experiment, and a mixed Logit regression model was used to analyze student parental HPV vaccine selection preferences.

Results  The self-paid cost, cervical cancer protection rate and side reaction all significantly affected the HPV vaccine choice preference (P<0.05). Overall, the parents of urban and rural students preferred the same HPV vaccine choice, and both valued the cervical cancer protection rate of the vaccine the most, followed by vaccine side effects.

Conclusion  Relevant institutions should actively explore HPV vaccination plans in terms of self funded expenses, cervical cancer protection rate, and side effects based on the preferences of HPV vaccines. At the same time, health education for middle school girls should be strengthened so as to improve the HPV vaccination rate.

1.Buskwofie A, David-West G, Clare CA, et al. A review of cervical cancer: incidence and disparities[J]. J Natl Med Assoc, 2020, 112(2): 229-232. DOI: 10.1016/j.jnma. 2020.03.002.

2.Hu Z, Ma D. The precision prevention and therapy of HPV-related cervical cancer: new concepts and clinical implications[J]. Cancer Med, 2018, 7(10): 5217-5236. DOI: 10.1002/cam4.1501.

3.Arbyn M, Weiderpass E, Bruni L, et al. Estimates of incidence and mortality of cervical cancer in 2018: a worldwide analysis[J]. Lancet Glob Health, 2020, 8(2): e191-e203. DOI: 10.1016/S2214-109X(19)30482-6.

4.Shrestha AD, Neupane D, Vedsted P, et al. Cervical cancer prevalence, incidence and mortality in low and middle income countries: a systematic review[J]. Asian Pac J Cancer Prev, 2018, 19(2): 319-324. DOI: 10.22034/APJCP.2018.19.2.319.

5.陈少强,吴颖,谢艳,等. 2020-2022年湖南省326  824名宫颈癌筛查和健康体检者HPV感染率及亚型分布[J]. 中华肿瘤防治杂志, 2024, 31(7): 399-404. [Chen SQ, Wu Y, Xie Y, et al. HPV infection rate and subtype distribution among 326 824 cervical cancerscreening and health check ups in Hunan province from 2020 to 2022[J]. Chinese Journal of Cancer Prevention and Treatment, 2024, 31(7): 399-404.] DOI: 10.16073/j.cnki.cjcpt.2024.07.02.

6.Olusola P, Banerjee HN, Philley JV, et al. Human papilloma virus-associated cervical cancer and health disparities[J]. Cells, 2019, 8(6): 622. DOI: 10.3390/cells8060622.

7.Zhuoru Z, Fairley CK, Ong JJ, et al. Domestic HPV vaccine price and economic returns for cervical cancer prevention in China: a cost-effectiveness analysis[J]. Lancet Glob Health, 2020, 8(10): e1335-e1344. DOI: 10.1016/S2214-109X(20)30277-1.

8.Anderson SM. Human papillomavirus and cervical cancer[J]. Lancet, 2007, 370(9590): 890-907. DOI: 10.1016/S0140-6736(07)61416-0.

9.Petrosky E, Bocchini JA, Hariri S, et al. Use of 9-valent human papillomavirus (HPV) vaccine: updated HPV vaccination recommendations of the advisory committee on immunization practices[J]. MMWR Morb Mortal Wkly Rep, 2015, 64(11): 300-304. https://pubmed.ncbi.nlm.nih.gov/25811679/.

10.梁辉,唐婷婷,吕华坤,等. 中小学生家长关于女儿接种HPV疫苗的知识和意愿调查[J]. 预防医学, 2021, 33(9): 884-888. [Liang H, Tang TT, Lyu HK, et al. Survey of parents' knowledge and willingness to vaccinate their daughters against HPV[J]. Journal of Preventive Medicine, 2021, 33(9): 884-888.] DOI: 10.19485/j.cnki.issn2096-5087.2021.09.005.

11.宋全全,张英辉,文大荣,等. 广元市中小学女生家长HPV疫苗犹豫现状及影响因素[J]. 公共卫生与预防医学, 2023, 34(3): 114-118. [Song QQ, Zhang YH, Wen DR, et al. Current situation and influencing factors of HPV vaccine hesitation among parents of primary and secondary school girls in Guangyuan city[J]. Journal of Public Health and Preventive, 2023, 34(3): 114-118.] DOI: 10.3969/j.issn.1006-2483.2023.03.025.

12.王天宇,邓景景,栾琳,等. 苏州市9~15岁女生母亲HPV疫苗免费供应方案选择意愿调查[J]. 中国公共卫生, 2023, 39(6): 758-761. [Wang TY, Deng JJ, Luan L, et al. Investigation on the willingness to choose HPV vaccine free supply scheme for parents of 9-15 year old female students in Suzhou city[J]. Chinese Journal of Public Health, 2023, 39(6): 758-761.] DOI: 10.11847/zgggws 1140930.

13.Mariani L, Preti M, Cristoforoni P, et al. Overview of the benefits and potential issues of the nonavalent HPV vaccine[J]. Int J Gynaecol Obstet, 2017, 136(3): 258-265. DOI: 10.1002/ijgo.12075.

14.Umar N, Quaife M, Exley J, et al. Toward improving respectful maternity care: a discrete choice experiment with rural women in northeast Nigeria[J]. BMJ Glob Health, 2020, 5(3): e002135. DOI: 10.1136/bmjgh-2019-002135.

15.刘世蒙,夏志远,傅佩芬,等. 乳腺癌患者中心静脉输液装置选择偏好和支付意愿初步分析[J]. 中国循证医学杂志, 2022, 22(4): 380-386. [Liu SM, Xia ZY, Fu PF, et al. Preliminary analysis of preference and willingness to pay for central venous infusion device in breast cancer patients[J]. Chinese Journal of Evidence-Based Medicine, 2022, 22(4): 380-386.] DOI: 10.7507/1672-2531.202112067.

16.Chyderiotis S, Sicsic J, Raude J, et al. Optimising HPV vaccination communication to adolescents: a discrete choice experiment[J]. Vaccine, 2021, 39(29): 3916-3925. DOI: 10.1016/j.vaccine.2021.05.061.

17.Zhu S, Chang J, Hayat K, et al. Parental preferences for HPV vaccination in junior middle school girls in China: a discrete choice experiment[J]. Vaccine, 2020, 38(52): 8310-8317. DOI: 10.1016/j.vaccine.2020.11.020.

18.Mcdougall JA, Furnback WE, Wang BCM, et al. Understanding the global measurement of willingness to pay in health[J]. J Mark Access Health Policy, 2020, 8(1): 1717030. DOI:10.1080/20016689.2020.1717030.

19.苏天园,李豫凯,张其其,等. 基于离散选择实验的乌鲁木齐市居民健康管理服务选择偏好研究[J]. 中国全科医学, 2021, 24(16): 2015-2021. [Su TY, Li YK, Zhang QQ, et al. Study on preference of health management service choice of Urumqi residents based on discrete choice experiment[J]. Chinese General Practice, 2021, 24(16): 2015-2021.] DOI: 10.12114/j.issn.1007-9572. 2021.00.101.

20.Thu HD, Thanh HN, Thanh TH, et al. Mothers' willingness to pay for daughters' HPV vaccine in northern Vietnam[J]. Health Care Women Int, 2018, 39(4): 450-462. DOI: 10.1080/07399332.2017.1411914.

21.Wong CKH, Man KKC, Ip P, et al. Mothers' preferences and willingness to pay for human papillomavirus vaccination for their daughters: a discrete choice experiment in Hong Kong[J]. Value Health, 2018, 21(5): 622-629. DOI: 10.1016/j.jval.2017.10.012.

22.Nasrin S, Amirhossein T, Mehdi Y, et al. Mothers' preferences and willingness-to-pay for human papillomavirus vaccines in Iran: a discrete choice experiment study[J]. Prev Med Rep, 2021, 23: 101438. DOI: 10.1016/j.pmedr.2021.101438.

23.Sarikapan W, Malika K, Sean K. Worldwide initiatives to eliminate cervical cancer[J]. Int J Gynaecol Obstet, 2021, 155(3): 102-106. DOI: 10.1002/ijgo.13879.

24.Yin G, Zhang YL, Chen CY, et al. Have you ever heard of human papillomavirus (HPV) vaccine? The awareness of HPV vaccine for college students in China based on Meta-analysis[J]. Hum Vaccin Immunother, 2021, 17(8): 2736-2747. DOI: 10.1080/21645515.2021.1899731.